Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $108.31 | 3 | 89.5% |
| Education | $12.70 | 1 | 10.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $87.65 | 2 | $0 (2017) |
| BioFire Diagnostics, LLC | $20.66 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $12.70 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $20.66 | 1 | BioFire Diagnostics, LLC ($20.66) |
| 2020 | $12.70 | 1 | Merck Sharp & Dohme Corporation ($12.70) |
| 2017 | $87.65 | 2 | PFIZER INC. ($87.65) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/26/2021 | BioFire Diagnostics, LLC | FilmArray (Device) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Clinical Diagnostics | ||||||
| 01/22/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/04/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $76.99 | General |
| Category: DERMATOLOGY | ||||||
| 10/04/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 84 | 121 | $17,916 | $6,888 |
| 2022 | 5 | 167 | 231 | $45,660 | $13,073 |
| 2021 | 7 | 290 | 426 | $83,272 | $25,042 |
| 2020 | 3 | 222 | 317 | $63,303 | $20,385 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 73 | $7,983 | $3,830 | 48.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 32 | 34 | $6,919 | $1,911 | 27.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $3,014 | $1,147 | 38.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 113 | $15,252 | $4,693 | 30.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 46 | 49 | $8,923 | $2,373 | 26.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 32 | $8,348 | $2,366 | 28.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $8,679 | $2,199 | 25.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $4,458 | $1,442 | 32.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 96 | 221 | $37,804 | $11,474 | 30.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 54 | 55 | $17,673 | $4,956 | 28.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 85 | 87 | $14,670 | $4,529 | 30.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $7,724 | $2,403 | 31.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 17 | $4,106 | $1,318 | 32.1% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 14 | 15 | $785.25 | $217.23 | 27.7% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 14 | 15 | $509.85 | $145.34 | 28.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 87 | 175 | $29,349 | $9,281 | 31.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 67 | 70 | $22,051 | $7,170 | 32.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 68 | 72 | $11,902 | $3,934 | 33.1% |
About Dr. James Spackman, MD
Dr. James Spackman, MD is a Internal Medicine healthcare provider based in Burley, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235203977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Spackman, MD has received a total of $121.01 in payments from pharmaceutical and medical device companies, with $20.66 received in 2021. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($108.31).
As a Medicare-enrolled provider, Spackman has provided services to 763 Medicare beneficiaries, totaling 1,095 services with total Medicare billing of $65,388. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Burley, ID
- Active Since 11/17/2006
- Last Updated 10/01/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235203977
Products in Payments
- EUCRISA (Drug) $76.99
- FilmArray (Device) $20.66
- ZERBAXA (Drug) $12.70
- VIAGRA (Drug) $10.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.